Abstracts tagged "psoriatic arthritis and treatment guidlelines"

Abstract Number: 634 • 2017 ACR/ARHP Annual Meeting
International League of Associations for Rheumatology. Systematic Review of the Literature to Inform Treatment Recommendations for Psoriatic Arthritis in Resource-Poor Countries
Musaab Elmamoun¹, Maria Eraso², Laura C Coates³, Ajesh Maharaj⁴, Vinod Chandran⁵, Ahmed Abogamal⁶, Valderilio F Azevedo⁷, Wilson Bautista-Molano⁸, Alex G. Ortega⁹, Jorge Medina-Rosas^10,11, Fabian Hernandez^12,13, Adma Lima¹⁴, Uyi Ima-Edomwonyi¹⁵, Adeola Ajibade¹⁶, Tarun Narang¹⁷, Olusola Ayanlowo¹⁸, Claudia Goldenstein-Schainberg¹⁹, Roberto Ranza^{20,21,22,23,24,25}, Girish M Mody²⁶, Sueli Carneiro^27,28, Aman Sharma²⁹, Oscar Vega-Hinojosa³⁰, Luis E. Vega³¹, Adewale O Adebajo³² and Sergio Toloza³³, ¹Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²University of Toronto, Toronto Western Hospital, Tornoto, ON, Canada, ³Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences,, Oxford, United Kingdom, ⁴Nelson R. Mandela School of Medicine, University of KwaZulu Natal, Durban, South Africa, ⁵Medicine, Krembil Research Institute, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, ⁶Al-Azhar University, Cairo, Egypt, ⁷Adjunct Professor of Rheumatology, Federal University of Paraná; Brazil, Curitiba, Brazil, ⁸School of Medicine, Universidad Militar Nueva Granada and Rheumatology Department Hospital Militar. Colombia, Bogotá, Colombia, ⁹Virginia Commonwealth University, Richmond, VA, ¹⁰Rheumatology, Universidad de la Sabana, Bogota, Colombia, ¹¹Universidad del Valle, Cali, Colombia, ¹²Universidad del Cauca, Popayan, Colombia, ¹³Universidad de Caldas, Pereira, Colombia, ¹⁴Federação Universidade Regional de Blumenau, Blumenau, Brazil, ¹⁵Internal Medicine, Lagos University Teaching Hospital, Surulere, Nigeria, ¹⁶Obafemi Awolowo University Teaching Hospitals Complex Osun state, Nigeria., Osogbo, Nigeria, ¹⁷Postgraduate Institute of Medical Education and Research, Chandigarh, India, ¹⁸Lagos University Teaching Hospital, Lagos, Nigeria, ¹⁹Universidade de São Paulo, São Paulo, Brazil, ²⁰on behalf of the BiobadaBrasil study group, Sociedade Brasileira de Reumatologia, Uberlandia, Brazil, ²¹Rua Otavio Rodrigues DaCunha, Uberlandia MG, Brazil, ²²Servicio de Reumatología, Universidade Federal de Uberlandia, Uberlandia, Brazil, ²³Reumatologia, Reumatologia, Universidade Federal de Uberlandia, Uberlandia, Brazil, ²⁴Matematica, Matematica, Universidade Federal de Uberlandia, Uberlandia, Brazil, ²⁵Universidade Federal de Uberlandia, Uberlandia MG, Brazil, ²⁶Dept of Rheumatology, University of Kwa Zulu-Natal, Durban, South Africa, ²⁷Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil, ²⁸University of São Paulo, Sao Paulo, Brazil, ²⁹Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India, ³⁰Clínica Reumacenter,, Juliaca, Peru, ³¹Hospita Central Fuerza Aerea Perú, Lima, Peru, ³²University of Sheffield, Sheffield, United Kingdom, ³³Rheumatology, Hospital San Juan Batista, Catamarca, Argentina, Catamarca, Argentina
Background/Purpose: Psoriatic Arthritis (PsA) is a heterogeneous disease which makes management of PsA a challenge. European League Against Rheumatism (EULAR) and the Group for Research…
Abstract Number: 7L • 2015 ACR/ARHP Annual Meeting
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): Treatment Recommendations for Psoriatic Arthritis 2015
Laura C Coates^1,2, Arthur Kavanaugh³, Philip J. Mease⁴, Enrique R. Soriano⁵, M Laura Acosta-Felquer⁶, April W Armstrong⁷, Wilson Bautista-Molano⁸, Wolf-Henning Boehncke⁹, Willemina Campbell¹⁰, Alberto Cauli¹¹, Luis Espinoza¹², Oliver FitzGerald¹³, Dafna D. Gladman¹⁴, Alice B. Gottlieb¹⁵, Philip S. Helliwell², M. Elaine Husni¹⁶, Thorvardur Love^17,18, Ennio Lubrano¹⁹, Neil J McHugh²⁰, Peter Nash²¹, Alexis Ogdie-Beatty²², Ana-Maria Orbai²³, Andrew Parkinson²⁴, Denis O'Sullivan²⁵, Cheryl F Rosen²⁶, Sergio Schwartzman²⁷, Evan Siegel²⁸, Sergio Toloza²⁹, William Tuong³⁰ and Christopher T. Ritchlin³¹, ¹Medicine, University of Rochester, Rochester, NY, ²Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, ³University of California San Diego, La Jolla, CA, ⁴Rheumatology Research, Swedish Medical Center, Seattle, WA, ⁵Rheumatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ⁶Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ⁷Keck School of Medicine, University of Southern California, Los Angeles, CA, ⁸Department of Rheumatology, Faculty of Medicine HMC/UMNG, Bogota, Colombia, Bogotá, Colombia, ⁹Department of Dermatology,, Geneva University Hospital, Geneva, Switzerland, ¹⁰Toronto Western Hospital, Toronto, ON, Canada, ¹¹University of Cagliari, Cagliari, Italy, ¹²Medicine-Section of Rheumatology, LSU Medical Center, New Orleans, LA, ¹³Department of Rheumatology, St. Vincent’s University Hospital, UCD School of Medicine and Medical Sciences and Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland, ¹⁴Division of Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, ¹⁵Tufts Medical Center, Boston, MA, ¹⁶Rheumatology Dept A50, Cleveland Clinic, Cleveland, OH, ¹⁷Faculty of Medicine, University of Iceland, Reykjavik, Iceland, ¹⁸Landspitali University Hospital, Reykjavík, Iceland, ¹⁹Cattedra di Reumatologia, Università del Molise, Campobasso, Italy, ²⁰Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, ²¹Department of Medicine, University of Queensland, Brisbane, Australia, ²²Medicine/Rheumatology, Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, ²³Rheumatology, Johns Hopkins University, Baltimore, MD, ²⁴Chapel Allerton Hospital, Leeds, United Kingdom, ²⁵St. Vincent’s University Hospital, Dublin, Ireland, ²⁶Division of Dermatology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, ²⁷Rheumatology, Hospital for Special Surgery, New York, NY, ²⁸Arthritis & Rheumatism Assoc, Wheaton, MD, ²⁹Rheumatology, Ministry of Health, San Fernando del Valle de Catamarca, Argentina, ³⁰Department of Dermatology, University of California David, Davis, CA, ³¹Allergy, Immunology and Rheumatololgy Division, University of Rochester Medical Center, Rochester, NY
Background/Purpose: Since the 2009 GRAPPA treatment recommendations were published, therapeutic options and management strategies for psoriatic arthritis (PsA) have advanced considerably. We updated and improved…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].